Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    83.76
    +0.95 (+1.15%)
     
  • GOLD FUTURES

    2,344.40
    +6.00 (+0.26%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,783.11
    +611.49 (+1.19%)
     
  • CMC Crypto 200

    1,397.62
    +15.05 (+1.09%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Is Editas the Best Genetics Stock to Buy?

There are some big opportunities in the gene editing space over the coming decades. In this Fool Live video clip, recorded on May 24, Fool.com Healthcare Bureau Chief Corrine Cardina, contributor Brian Orelli, PhD, and Chief Growth Officer Anand Chokkavelu discuss Editas Medicine (NASDAQ: EDIT) and why it could be a good stock to put on your radar. Editas has a strong pipeline further out.